USNA

USNA

USD

USANA Health Sciences Inc. Common Stock

$27.180+0.180 (0.667%)

Prix en Temps Réel

Consumer Defensive
Aliments emballés
États-Unis

Graphique des Prix

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$27.000

Haut

$27.190

Bas

$26.460

Volume

0.01M

Fondamentaux de l'Entreprise

Capitalisation Boursière

512.6M

Industrie

Aliments emballés

Pays

United States

Statistiques de Trading

Volume Moyen

0.22M

Bourse

NYQ

Devise

USD

Intervalle sur 52 Semaines

Bas $23.1Actuel $27.180Haut $49.78

Rapport d'Analyse IA

Dernière mise à jour: 23 avr. 2025
Généré par l'IASource des Données: Yahoo Finance, Bloomberg, SEC

USNA: USANA Health Sciences Inc. Common Stock - Analyzing Recent Moves & What Might Come Next

Stock Symbol: USNA Generate Date: 2025-04-23 13:48:15

Alright, let's break down what's been going on with USANA Health Sciences stock lately. We'll look at the latest news, check out how the price has been moving, and see what some automated predictions are saying.

Recent News Buzz

The big news hitting the wires just yesterday (April 22nd) was USANA's report on their first quarter results for 2025. The headline mentioned net sales hitting $250 million and, importantly, that the company is sticking with its full-year outlook. Now, the news snippet we have doesn't give us all the details like profit or earnings per share, but reiterating the full-year outlook often suggests management feels reasonably confident about where things are headed, even if the sales figure itself needs more context.

Before that, back on April 14th, there was a positive piece about a clinical study showing one of their skincare products, Celavive's Resurfacing Serum, improved skin appearance pretty quickly. That's good news for that specific product line, showing it's backed by some science, which can help sales.

So, the vibe from the news is primarily focused on the recent earnings report. Sticking to the full-year outlook after Q1 is generally seen as a steady sign, not necessarily spectacular, but not a red flag either, based just on the headline. The skincare study is a nice little bonus.

Price Check

Looking at the stock's journey over the last month or so, it's been a bit of a bumpy ride, mostly trending downwards. Back in late March, shares were trading in the $27-$28 range. Then, through early April, the price slid quite a bit, dipping down towards the $24-$25 area.

But then came today, April 23rd. Wow, what a jump! The stock opened significantly higher than yesterday's close and has climbed sharply, hitting highs around $28.19. This kind of move right after an earnings announcement usually means the market liked something in that report, even if the news snippet didn't spell it all out. The volume today isn't huge yet compared to the average, but the price reaction is undeniable.

Now, the AI prediction for today said 0.00% change, which clearly didn't capture this post-earnings surge at all. For tomorrow, the AI actually predicts a dip of about 2.86%, followed by a small gain the day after (+0.96%). This suggests the AI thinks today's big move might not hold entirely.

Outlook & Ideas

Putting it all together, the dramatic price jump today, right after the earnings report, seems to be the dominant factor right now. Despite the stock's recent slide leading up to the report and the AI predicting a dip after today, the market's immediate reaction is strongly positive. This suggests the Q1 results or the reiterated outlook were better received than the prior price trend might have indicated.

So, the apparent near-term leaning, based purely on today's price action tied to the earnings news, seems bullish. The stock is showing strong momentum right now.

What might someone consider doing? Well, the big move has already happened today. Trying to jump in right at the peak of a sudden surge can be risky. One possible strategy could be to watch if this momentum continues or if the stock consolidates (trades sideways) after this initial reaction. If it pulls back slightly but holds above a key level like today's open ($25.50) or even yesterday's close ($24.24), that might be seen by some as a potential entry point if they believe the positive reaction will last.

For managing risk, setting a stop-loss is always smart. A potential level to consider for a stop-loss could be below today's open ($25.50) or perhaps below yesterday's close ($24.24). If the price falls back below those levels, it could signal that today's jump was just a temporary reaction. As for taking profits, the AI predicts a dip tomorrow, which could suggest a very short-term trader might look to lock in gains quickly, but predicting the exact top is impossible. Watching for signs of the momentum slowing down or hitting resistance levels would be key.

Company Context

Just remember, USANA is in the Packaged Foods/Consumer Defensive sector. This means their business is generally less sensitive to economic ups and downs compared to, say, tech or retail. However, they operate with a direct selling model, which has its own unique dynamics and challenges. They are also a relatively small company with a market cap around $531 million, which can sometimes mean more volatile price swings compared to larger companies. The company details also point out some fundamental challenges like negative revenue growth and high debt, which are worth keeping in mind beyond the short-term price action driven by earnings.


Disclaimer: This analysis is for informational purposes only and is based solely on the provided data. It is not financial advice. Stock investing involves risk, and you could lose money. Always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

Actualités Connexes

BusinessWire

USANA Health Sciences Reports First Quarter 2025 Results and Reiterates Full-Year Outlook

USANA Health Sciences, Inc. (NYSE:USNA) today announced financial results for its fiscal first quarter ended March 29, 2025. Key Financial Results First Quarter 2025 vs. First Quarter 2024 Net sales of $250 million

Voir plus
USANA Health Sciences Reports First Quarter 2025 Results and Reiterates Full-Year Outlook
PR Newswire

Clinical Study Shows USANA Celavive's Resurfacing Serum to Improve Appearance of Skin in Just Two Weeks

USANA Health Sciences, Inc., a global leader in cellular nutrition, recently conducted a clinical study on its Celavive Resurfacing Serum to evaluate ...

Voir plus
Clinical Study Shows USANA Celavive's Resurfacing Serum to Improve Appearance of Skin in Just Two Weeks
BusinessWire

USANA Schedules First Quarter 2025 Earnings Release and Conference Call

USANA Health Sciences, Inc. (NYSE:USNA) today announced that first quarter 2025 results will be released after the close of market on Tuesday, April 22, 2025. Shortly following the issuance of the Company's earnings

Voir plus
USANA Schedules First Quarter 2025 Earnings Release and Conference Call

Prédiction IABeta

Recommandation IA

Baissier

Mis à jour le: 28 avr. 2025, 02:18

BaissierNeutreHaussier

59.6% Confiance

Risque et Trading

Niveau de Risque3/5
Risque Moyen
Adapté Pour
Valeur
Guide de Trading

Point d'Entrée

$26.86

Prise de Bénéfices

$27.72

Stop Loss

$25.66

Facteurs Clés

Le PDI 14.9 est au-dessus du MDI 10.2 avec un ADX de 15.5, suggérant une tendance haussière
Le cours actuel est extrêmement proche du niveau de support ($26.96), suggérant une forte opportunité d'achat
Le volume de transactions est 10.4x la moyenne (2,557), indiquant une pression d'achat extrêmement forte
Le MACD 0.0305 est en dessous de la ligne de signal 0.0332, indiquant un croisement baissier

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.